Document Information
Pharmaceutical Technology Assessment for Managed Care: Current Practice and Suggestions for Improvement
Powerful pharmaceuticals are of increasing clinical and economic importance to managed care organizations, which are often responsible for managing and paying for the increasing costs of pharmaceuticals. This creates an incentive for them to go beyond a focus on clinical effectiveness and safety to evaluate the cost-effectiveness of new drugs. This report describes the processes by which managed care organizations evaluate pharmaceutical technologies and suggests pathways for organizing improvement. It reviews current evaluation procedures, provides a framework for future evaluations, introduces evaluation approaches, and annotates resources for further research on each topic covered. The report finds that most managed care organizations have internal procedures for assessing new pharmaceutical technologies, but their medical directors commonly believe these procedures to be less rigorous and less systematic than are desirable. The decisionmaking framework outlined in the report and the techniques it incorporates describe an objective, reproducible process for assessing pharmaceutical technology in the managed care setting. It provides a road map that can help an organization expose hidden biases in current processes, build on its experiences with evaluation, and reduce the risk of illogical or poorly thought-through decisions.
Support RAND Research — Buy This Product!
Paperback Cover Price: $20.00
Discounted Web Price: $18.00
Pages: 81
ISBN/EAN: 0-8330-3124-4
Free, downloadable PDF file(s) are available below.
RAND makes an electronic version of this document available for free as a public service. If you find this information valuable, please consider purchasing a paper copy of the full document to help support RAND research.
Use Adobe Acrobat Reader version 7.0 or higher for the best experience.
The research described in this report was performed under the auspices of RAND Health.
The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit research organization providing objective analysis and effective solutions that address the challenges facing the public and private sectors around the world. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.
* RAND research is conducted across divisions, centers, and projects; these organizational components are represented in the "Related RAND Divisions" section above.
Top
RAND® is a registered trademark. Copyright © 1994-2009 RAND Corporation. Last Modified: December 07, 2007 